TCG Opportunity III GP, LLC, 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 5,378 shares at $4.95 ($27K) on 2023-01-12, disclosed to the SEC on 2023-01-17.
Recurring purchase ($27k) by 10% Owner following this insider's established cadence. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| NGM | BUY | 2023-02-01 | $921K | — | Filing → |
| NGM | BUY | 2023-01-23 | $191K | — | Filing → |
| NGM | BUY | 2022-12-14 | $1K | — | Filing → |